Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2010
11/18/2010US20100292402 Compositions that reversibly gel and de-gel
11/18/2010US20100292312 Anti-dll4 antibodies and methods using same
11/18/2010US20100292311 Oligomeric compounds for the modulation of survivin expression
11/18/2010US20100292310 Micro-rna scaffolds and non-naturally occurring micro-rnas
11/18/2010US20100292309 Inducing immune-mediated tumor cell death
11/18/2010US20100292308 Microrna molecules
11/18/2010US20100292307 Construct
11/18/2010US20100292305 RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF
11/18/2010US20100292302 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity
11/18/2010US20100292301 Novel sirna structures
11/18/2010US20100292299 Nucleotide Motifs Providing Localization Elements and Methods of Use
11/18/2010US20100292162 Socs-3 promoter methylation in cancer
11/18/2010US20100292161 Polypeptides and methods of use
11/18/2010US20100292160 Hla-a* 3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/18/2010US20100292154 Protein profile for osteoarthritis
11/18/2010US20100292152 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/18/2010US20100292140 Antisense modulation of fibroblast growth factor receptor 4 expression
11/18/2010US20100292130 Biological active proteins having increased in vivo and/or in vitro stability
11/18/2010US20100292099 Targeting of rna with external guide sequences
11/18/2010US20100292097 Complexity Management of Genomic DNA
11/18/2010US20100292095 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
11/18/2010US20100291706 Dye conjugates and methods of use
11/18/2010US20100291682 System for transposing hyperactive recombinant derivatives of mos-1 transposon
11/18/2010US20100291681 Methods and compositions for selecting siRNA of improved functionality
11/18/2010US20100291676 Humanized anti-cd4 antibody with immunosuppressive properties
11/18/2010US20100291673 Alternative export pathways for vector expressed rna interference
11/18/2010US20100291655 Novel glucose dehydrogenase and method for producing the dehydrogenase
11/18/2010US20100291651 Recombinant hydrogen-producing cyanobacterium and uses thereof
11/18/2010US20100291647 Microorganisms Having Enhanced Resistance To Acetate And Related Compositions And Methods of Use
11/18/2010US20100291645 Xylose reductase mutants and uses thereof
11/18/2010US20100291642 Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor
11/18/2010US20100291638 Thermostable dna polymerases and methods of use
11/18/2010US20100291634 Annealing control primer and its uses
11/18/2010US20100291631 Novel Beta-Galactoside-Alpha 2,3-Sialyltransferase, a Gene Encoding Thereof, and a Method for Producing Thereof
11/18/2010US20100291625 Regulation of translation of heterologously expressed genes
11/18/2010US20100291624 Compositions and methods for improved glycoprotein sialylation
11/18/2010US20100291616 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/18/2010US20100291607 Transformed cell with enhanced sensitivity to antifungal compound and use thereof
11/18/2010US20100291586 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
11/18/2010US20100291585 Methods and compositions for diagnosing complications of pregnancy
11/18/2010US20100291579 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
11/18/2010US20100291574 Genotyping Assay to Predict Gamma Glutamyl Hydrolase (GGH) Activity
11/18/2010US20100291561 Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex
11/18/2010US20100291560 Methods and compositions for diagnosis and treatment of dyskeratosis congenita and related disorders
11/18/2010US20100291559 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
11/18/2010US20100291557 Binary probe and clamp composition and methods for target hybridization detection
11/18/2010US20100291556 Isolated aebp1 genomic polynucleotide fragments from chomosome 7 and their uses
11/18/2010US20100291555 Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium by using the primer or probe
11/18/2010US20100291552 DETECTION OF MUTATIONS IN A GENE ENCODING IkB KINASE-COMPLEX-ASSOCIATED PROTEIN TO DIAGNOSE FAMILIAL DYSAUTONOMIA
11/18/2010US20100291550 Methods and compositions for modulating hair growth
11/18/2010US20100291547 Fluorogenic hydrazine-substituted compounds
11/18/2010US20100291485 Nanoscale molecule synthesis
11/18/2010US20100291262 Lipolytic Enzyme Variants
11/18/2010US20100291218 Immunomodulatory compositions, formulations, and methods for use thereof
11/18/2010US20100291194 Compositions and Methods for Inhibiting Expression of a Mutant Gene
11/18/2010US20100291156 Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
11/18/2010US20100291153 Vaccines against bordetella pertussis based on lps glycosyltransferase mutants
11/18/2010US20100291150 Pseudomonas exotoxin a cd4+ t-cell epitopes
11/18/2010US20100291143 Inhibition of HIV and SHIV Replication with Antisense Interleukin-4
11/18/2010US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
11/18/2010US20100291131 Clostridial toxin netb
11/18/2010US20100291125 Eta-1 gene and methods for use
11/18/2010US20100291124 Extracellular serine protease
11/18/2010US20100291123 T Cell Receptor CDR3 Sequences and Methods for Detection
11/18/2010US20100291120 Peptides regulating the surface expression of the t cell receptor
11/18/2010US20100291118 Class of Gamma Delta T Cells Activators and Use Thereof
11/18/2010US20100291109 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
11/18/2010US20100291108 Antibodies to irem-1
11/18/2010US20100291106 Compositions and methods for antibodies targeting complement protein c3b
11/18/2010US20100291105 Agent for the treatment of malignant diseases
11/18/2010US20100291104 Bordetella outer-membrane protein antigens and methods of making and using the same
11/18/2010US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor
11/18/2010US20100291091 Cancer associated gene ly6k
11/18/2010US20100291088 Il-18 binding proteins
11/18/2010US20100291086 Use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers
11/18/2010US20100291081 Rage fusion proteins
11/18/2010US20100291079 Heterodimeric Follicle Stimulating Hormone-Fc (FSH-Fc) Fusion Proteins for the Treatment of Infertility
11/18/2010US20100291078 Proteinaceous binding molecules comprising purification tags or inert variable domains
11/18/2010US20100291076 Antibodies specific for dkk-1 and their uses
11/18/2010US20100291072 Antibody variants with faster antigen association rates
11/18/2010US20100291068 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
11/18/2010US20100291059 Pharmaceutical composition for enzyme replacement therapy
11/18/2010US20100291048 Modification of CXCR4 using engineered zinc finger proteins
11/18/2010US20100291036 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
11/18/2010US20100291033 Albumin Fusion Proteins
11/18/2010US20100291032 Compositions and methods for the identification of inhibitors of retroviral infection
11/18/2010US20100291001 Metalloproteinase-binding proteins
11/18/2010US20100290993 Antibodies to IL-6 and use thereof
11/18/2010US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs
11/18/2010US20100290984 Anti-mrp3 antibodies and methods of use
11/18/2010CA2761749A1 Sirna conjugate and preparation method thereof
11/18/2010CA2761533A1 Plant promoter operable in basal endosperm transfer layer of endosperm and uses thereof
11/18/2010CA2759838A1 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes
11/17/2010EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
11/17/2010EP2251015A1 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
11/17/2010EP2250282A2 Methods of diagnosing and treating parp-mediated diseases
11/17/2010EP2250267A1 Cationic sirnas, synthesis and use for interfering rna
11/17/2010EP2250184A1 Treatment of chronic pain with zinc finger proteins
11/17/2010EP2250182A1 Isolation of dna, rna and protein from a single sample
11/17/2010EP1804836B1 Methods of diagnosing and treating complications of pregnancy
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 899